Navigation Links
AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
Date:6/25/2013

IRVINE, Calif., June 25, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the initiation of a Phase 1 clinical trial with its lead compound, AHRO-001.  The Phase 1 study will evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

"There is a significant unmet need for effective and well-tolerated agents in the treatment of both atherosclerosis and lipid modulation," said Thomas W. Gardner, Chairman and Chief Executive Officer of AtheroNova.  "Based on AHRO-001's preclinical profile, we believe it has the potential to offer patients effective treatment for these chronic conditions with an improved therapeutic profile.  We look forward to assessing AHRO-001 in human trials and are extremely pleased to have met a significant milestone with transitioning into a clinical stage company."

The Phase 1 study is a randomized, double-blind, placebo controlled study that assesses ascending doses of AHRO-001 in healthy adult volunteers.  The program advanced into Phase 1 clinical testing following extensive successful preclinical studies with AHRO-001.

"This is clearly an exciting and transformative time for us," remarked Mark K. Wedel, MD, Chief Medical Officer of AtheroNova.

About AHRO-001

AHRO-001 is AtheroNova's first novel application for the treatment and prevention of atherosclerosis. Atherosclerotic plaque is the primary, underlying cause of heart disease and stroke in industrialized countries. AtheroNova has shown positive results in animal models for regression of pl
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AtheroNova Announces Milestone Filing of IND in Russian Federation
2. AtheroNova Receives Notice of Allowance for Its US Patent Application 12/024,908
3. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
4. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
5. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
6. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
7. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
8. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
9. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
10. ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
11. Romark Laboratories Initiates Phase 3 Trial of New Influenza Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... quantum dot market report analyzes the ecosystem of the quantum ... includes medical devices, display, and others. The others segment consists ... QD laser, and transistor. The application segment covers the market ... report also provides the geographic view for major regions like ... , Asia-Pacific (APAC), and Rest ...
(Date:9/2/2015)... Colo. , Sept. 2, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in Boston.  The public is welcome ... on the Array BioPharma website.Event: Wells Fargo Securities ... Thursday, September 10, 2015Time:  , 10:20 a.m. Eastern ...
(Date:9/2/2015)... STAAR Surgical Company (NASDAQ: STAA ), a ... systems for the eye, today announced that its Board of ... Company,s Board. Mr. Wall was formerly the ... -based investment firm, for more than nine years. Mr. Wall ... chair of the Corporate Governance Committee and member of the ...
Breaking Medicine Technology:Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2William P. Wall Appointed to STAAR Surgical Board of Directors 2
... 17, 2012  Tengion, Inc. (NASDAQ: TNGN ), ... recently completed a successful Pre-IND meeting with the U.S. ... program, the Neo-Kidney Augment™. The FDA and the Company ... study program required to support an Investigational New Drug ...
... Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" ... Distribution Specialists, LLC ("HDS") are pleased to announce that ... and Hemostasis Summit of North America (the "THSNA") to ... Chicago.  "Participation as an official exhibitor ...
Cached Medicine Technology:Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 2Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 3Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 4Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 5Sunpeaks Ventures to Exhibit Clotamin at the first-ever Thrombosis and Hemostasis Summit of North America 2
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world ... be spotlighting its award-winning print and artwork inspection solutions, ScanProof and ArtProof ... 17 at the Olympia London, booth #F33 , Be the first to get a ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... data collection, cloud analytics and workflow solutions today announced the complete faculty ... September 22-24, 2015. The esteemed faculty of worldwide pharmaceutical and industry experts ...
(Date:9/3/2015)... ... September 03, 2015 , ... “Love in Tokyo” an ... Google Play , and Amazon and will be released on DVD early ... Darling is a Foreigner,” Itsuka, an actress and singer/songwriter, and Jason London, lead from ...
(Date:9/3/2015)... ... ... types of people who have a hard time gaining weight , it seems that ... those that have a fast metabolism. In order to help those people who have a ... slowing down metabolism. , The first thing to do is to space out meals. When ...
(Date:9/3/2015)... ... September 03, 2015 , ... Doctor Kayode Sotonwa can be counted on ... His perspective on internal medicine keeps patients happy and healthy, something that is important ... of the season, but even more so in the fall, when holiday eating and ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2
... Access to Basic,Care plan could help thousands of ... of Community and Economic Development,Secretary Dennis Yablonsky said ... "The vast majority of Pennsylvania,s uninsured adults ... businesses that struggle to make a,profit," said Yablonsky. ...
... D,ALENE, Idaho, May 23 NightHawk,Radiology Holdings, Inc. ... radiology,solutions to radiology groups and hospitals throughout the ... the Goldman Sachs 29th Annual,Global Healthcare Conference in ... at,8:40 am PDT. Presenting at the conference will ...
... also lower cholesterol, study says , , FRIDAY, May ... in antioxidants and may help protect against liver damage, ... The berries of the plant -- indigenous to the ... well known for their high levels of antioxidants and ...
... Linkwell,Corporation (Linkwell) (OTC Bulletin Board: LWLL), a ... disinfectants in China,announced today that it was ... relief efforts. The Chinese government, non-government,organizations (NGOs) ... scale in response to the earthquake in ...
... John G. Rangos Sr. Research Center at Childrens Hospital ... for the development of new therapies to treat hypertriglyceridemia, ... obese and diabetic. Results of their study are published ... Investigation. , Scientists in the Division of Immunogenetics at ...
... make a world of difference for Singer Songwriter Katie ... Reider Beginning May 23, ... songwriter Katie Reider, age 29, has inspired the hearts of,thousands with ... across the country are banding together to help Katie,during her ongoing ...
Cached Medicine News:Health News:PA ABC Will Benefit Commonwealth's Small Businesses, DCED Secretary Says 2Health News:NightHawk Radiology Holdings, Inc. to Speak at the Goldman Sachs 29th Annual Global Healthcare Conference 2Health News:Linkwell Corporation Runs 24/7 Disinfectant Operations to Support China's Earthquake Relief Efforts 2Health News:Linkwell Corporation Runs 24/7 Disinfectant Operations to Support China's Earthquake Relief Efforts 3Health News:Pittsburgh scientists find protein may be key to new therapies for elevated triglycerides 2Health News:Katie Reider - Listen to Her Songs, Hear Her Story, Log Onto www.500kin365.org 2Health News:Katie Reider - Listen to Her Songs, Hear Her Story, Log Onto www.500kin365.org 3
... tray is specifically designed for a variety ... x 13.34cm dot blot transfer membranes. The ... a standard microplate for compatibility with various ... available dot blot membranes without trimming., With ...
Mini Trans-Blot and PowerPac 300 System, 110-120 V...
... The GENIE is the proven electrophoretic transfer apparatus ... field uniformity. Its design allows for a very ... with a low voltage power source such as ... volts/cm. The result is exceptionally rapid and exact ...
... transfer apparatus incorporating state-of-the-art plate electrodes for the ... a very close positioning of the electrodes which, ... such as a battery charger, creates a high ... and exact electrophoretic transfer. ...
Medicine Products: